Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Revenue

In the year 2025, Honz Pharmaceutical had annual revenue of 466.12M CNY, down -1.42%. Honz Pharmaceutical had revenue of 96.57M in the quarter ending March 31, 2026, a decrease of -14.09%.

• Revenue: 466.12M
• Revenue Growth: -0.72%
• P/S Ratio: 6.78
• Revenue / Employee: 707.32K
• Employees: 659
• Market Cap: 3.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	466.12M	-6.70M	-1.42%
Dec 31, 2024	472.82M	-266.75M	-36.07%
Dec 31, 2023	739.57M	203.82M	38.05%
Jan 1, 2023	535.75M	-300.82M	-35.96%
Jan 1, 2022	836.57M	-85.08M	-9.23%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error